Symptom scores over treatment periods
| Screening period | Fluticasone | p-value | Montelukast | p-value | |
| Daytime symptoms | 0.7±0.8 | 0.4±0.7 | 0.05 | 0.44±0.8 | 0.08 |
| Night-time symptoms | 0.35±0.5 | 0.19±0.5 | 0.17 | 0.27±0.5 | 0.49 |
| Salbutamol puff·day−1 | 1.5±1.8 | 0.8±1.7 | <0.001 | 1.0±1.8 | 0.02 |
Data are presented as mean±sd of changes over fluticasone and montelukast treatment periods and as absolute values during the screening period. A score of 0 denotes no symptoms; a score of 4 denotes maximal symptoms, severe impairment of daytime activities, and no sleep during night-time. n=38